Document Detail


A state of art review on vardenafil in men with erectile dysfunction and associated underlying diseases.
MedLine Citation:
PMID:  21548725     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Introduction: Erectile dysfunction (ED) is a common male sexual disorder among men. Many governing bodies advocate the use of oral PDE5 inhibitors as a first-line therapy for ED. The clinical efficacy of these PDE5 inhibitors has been demonstrated in a number of placebo-controlled trials and reported by many systematic reviews on the effectiveness of PDE5 inhibitors in restoring the erectile function and improved frequency of successful sexual intercourse attempts across different spectra of underlying diseases. Areas covered: This review article examines the drug profile of vardenafil and its role in restoring erectile function; highlights a number of clinical trials on vardenafil in men with underlying cardiovascular and metabolic conditions as well as in post-radical prostatectomy cases; and addresses the efficacy of vardenafil in comparison with other PDE5 inhibitors. Expert opinion: Given the multi-factorial nature of ED, a holistic approach should be taken when dealing with ED patients. There is a need for long-term surveillance and management of underlying medical conditions, and despite the strict adherence to all the necessary steps to maximize its efficacy, PDE5 inhibitors could still fail due to the potential drug intolerance, progression of underlying disease or development of medical conditions.
Authors:
Eric Chung; Gerald B Brock
Related Documents :
24082415 - Isolated atrial amyloidosis and the importance of molecular classification.
17921045 - Endings in the middle: current knowledge of interstitial telomeric sequences.
11979095 - Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, an...
2582825 - Correlation of chest roentgenograms with pulmonary function and bronchoalveolar lavage ...
19768775 - Hsp70 molecular chaperones and parkinson's disease.
16358365 - Patient, disease, and therapy-related factors that influence discontinuation of disease...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-5-6
Journal Detail:
Title:  Expert opinion on pharmacotherapy     Volume:  -     ISSN:  1744-7666     ISO Abbreviation:  -     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-5-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897346     Medline TA:  Expert Opin Pharmacother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Princess Alexandra Hospital, Department of Urology , Ipswich Rd., Brisbane, Queensland 4103 , Australia +617-33242468 ; +617-33242546 ; ericchg@hotmail.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Duloxetine use in painful conditions.
Next Document:  The quest for an optimized protocol for whole heart decellularization: A comparison of three popular...